Background {#Sec1}
==========

Hepatitis A and E virus (HAV and HEV) infections are heavy public health problems in developed and developing countries. It is estimated that over ten millions people have been infected by these two viruses every year worldwide \[[@CR1], [@CR2]\]. Both HAV and HEV are mainly transmitted via the fecal-oral route either by the contaminated food or water ingestion or via person-to-person contact. Although the disease of hepatitis A or hepatitis E is usually mild or asymptomatic, the higher incidences of fulminant hepatitis could be occurred in the HAV-infected elders and HEV-infected women in pregnant \[[@CR3], [@CR4]\].

In the past decade, Genome-wide association studies (GWAS) have been carried out rapidly and contributed to identify susceptible loci for many kinds of infectious diseases, such as malaria, tuberculosis, hepatitis B and C \[[@CR5]--[@CR7]\]. In a US study, Zhang et al. recently reported that Mexican Americans carrying the functional T allele of TGFβ1 rs1800469 and T allele of XRCC1 rs1799782 were more prone to be infected by HAV, while the minor allele (T) of ABCB1 rs1045642 was associated with lower risk for anti-HAV seropositivity \[[@CR8]\]. TGF-β1 is a multifunctional cytokine and involved in the pathogenesis of liver injury during acute HAV infection. Moreover, it has been reported that TT genotype of TGFB1 rs1800469 is significantly associated with higher plasma levels of TGF-β1 \[[@CR9]\]. XRCC1 is a major DNA repair gene so it has ability to repair DNA damage, which may be a requisite for risk of many infectious diseases \[[@CR10]\]. Recently, the results from a 10-year cohort study indicated that XRCC1 gene may be responsible for hepatocellular transformation in Chinese chronic hepatitis B patients \[[@CR11]\]. ABCB1 gene encodes one member of the ATP-binding cassette super family of membrane transporters. Up-regulated expression of ABCB1 in human hepatocytes in viral hepatitis may render the cells resistant to oxidative damage \[[@CR12]\].

In another study, Zhang et al. further reported that rs5110-C/A in APOA4 and rs7412-C/T in APOE were significantly associated with protection against HEV infection in non-Hispanic blacks in United States \[[@CR13]\]. Both APOA4 and APOE genes were recognized for their importance in lipoprotein metabolism and cardiovascular disease. However, more and more studies indicated that these two genes are not only play the key roles in lipid transport, but also involved in immunoregulation, which in turn can influence susceptibility to and the natural history of infectious disease \[[@CR14], [@CR15]\].

However, the associations of these loci with HAV or HEV infections have not been evaluated in other populations. Owing to its long history, large population, environmental pollution, and poor hygiene, both hepatitis A and E outbreaks and sporadic incidents are the major public health problems in China \[[@CR16], [@CR17]\]. Additionally, accumulative evidences demonstrated that the seroprevalence of HAV and HEV infections are very high in Han ethnic areas (\~ 60% and \~ 20% for anti-HAV IgG and anti-HEV IgG, respectively) \[[@CR16]\]. Given the additional evidences of genetic associations will improve our understanding of genetic factors and mechanisms truly influencing HAV or HEV infection, we performed the present study to evaluate the single-nucleotide polymorphisms (SNPs) recently reported to be associated with HAV or HEV infection in Chinese Han population.

Methods {#Sec2}
=======

Study participants and data collection {#Sec3}
--------------------------------------

This study was performed with 3082 Chinese Han persons from the Huai'an-09 Study, which is established in 2009 and is designed to investigate the health conditions of general populations in Huaian, China. Between April 2009 and September 2009, 3166 individuals (aged 30--75 yrs) were randomly selected from Huai'an city. All participants underwent questionnaire assessment, physical examination, and routine blood, urine, and biochemical tests at baseline without charge. All the doctors and nurses had rigorous unified training before they measured the anthropometric indices. Blood samples were obtained by venipuncture and stored at − 80 °C until further analysis.

In the current study, we excluded 84 persons including 83 individuals with HBsAg positive, one person with anti-HCV IgG positive. None of participants tested for antibodies to human immunodeficiency virus. In addition, people with hepatic fibrosis, diabetes, renal inadequacy and cancer were excluded. Eventually, 3082 persons were finally included in this study.

Laboratory testing {#Sec4}
------------------

Both anti-HAV IgG and anti-HEV IgG were detected by enzyme-linked immunosorbent assay (ELISA) with commercial reagents purchased from Wantai Bio, Beijing, China. According to the manufacturer's instructions, the sensitivity and specificity is 98% and 97% for the anti-HAV IgG detection, and 99% and 97% for anti-HEV IgG detection, respectively.

SNP selection and genotyping {#Sec5}
----------------------------

There were five SNPs have been reported to be associated with HAV infection in US GWAS studies \[[@CR8]\]. Because the minor allele frequency (MAF) of rs1799782 in XRCC1 was lower than 5% in Han Chinese, we analyzed the associations of rs1001581in XRCC1 (MAF: 0.44; LD: r^2^ \> 0.8 with rs1799782 in Caucasian population) with HAV infections in the present study. Additionally, the genotypes of rs1045642 in ABCB1, rs1800469 in TGFB1, and two SNPs marginally associated with anti-HAV (rs2031920 in CYP2E1 and rs769214 in CAT) were selected to evaluation according to the findings of Zhang's study \[[@CR8]\].

Rs5110 in APOA4 and rs7412 in APOE gene were reported to be associated with HEV infection in Zhang's study. However, MAF of rs5110 in Chinese population (HapMap) was much lower (MAF = 0 for CHB and MAF = 0.023 for HCB). We selected rs1268354 in the present study because rs1268354 is the only polymorphism with MAF \> 0.05 in APOA4 in Chinese population (MAF = 0.45). In addition, Zhang et al. suggested that there was a significant joint effect of rs7412 and rs429358 on HEV infection \[[@CR13]\]. Considering MAF of rs429358 was not available in Chinese population and rs429358 had lower LD (r^2^ \< 0.1) with rs405509 or rs769450 in Caucasian population, rs7412, rs405509 (MAF: 0.31) and rs769450 (MAF: 0.20) were selected to analysis in our present study.

Proteinase K digestion and phenol-chloroform extraction were used to isolate genomic DNA from EDTA-treated blood samples. Genotyping was performed using TaqMan MGB technology and 7900HT Fast Real-Time PCR System (Applied BioSystems, Foster City, CA, USA). The commercial reagents including primers and probes were ordred from Applied BioSystems and Biosteed Biotechnologies (Nanjing, China), respectively (Additional file [1](#MOESM1){ref-type="media"}: Table S1). According to the manufacture, the results from TaqMan assay used in the present study are in a concordance of 99.8--99.9% with the results from sequencing. The genotypes were determined automatically with the Sequence Detection System 2.1 software (95% autocaller confidence level). In the present study, 5% samples were duplicated and the results were in a concordance of 100%. The genotype-calling success rates were greater than 99.9%.

Statistical analysis {#Sec6}
--------------------

Fisher's exact test was used to test for Hardy-Weinberg equilibrium (HWE). The genotype and allele distribution were analyzed using chi-squared (χ^2^) tests. The odds ratio (OR) and 95% confidence intervals (CI) were calculated by logistic regression (adjusted for age and gender) and used to test for the risk of associations. All of the statistical analyses were performed with SPSS version 17.0 (SPSS, Inc., Chicago, USA). A two-tailed *P* \< 0.05 was considered statistically significant.

Results {#Sec7}
=======

Characteristics of studied population {#Sec8}
-------------------------------------

Totally, 1655 males and 1427 females were included in the present study, the mean age of males and females were 44.84 ± 8.45 and 44.58 ± 8.50 years, respectively. No significant difference was observed between males and females (Table [1](#Tab1){ref-type="table"}).Table 1Characteristic of HAV IgG and HEV IgG antibody in studied populationCharacteristicHAV IgGHEV IgGPositive (*n* = 2375)Negative(*n* = 707)χ^2^/*tP*-valuePositive (*n* = 885)Negative(*n* = 2194)χ^2^/*t*P-valueAge (Years)45.33 ± 8.3542.66 ± 8.767.376\<0.00145.89 ± 8.5344.24 ± 8.474.884\<0.001 30-519(65.5%)2327(34.5%)174(22.0%)618(70.8%) 40-1284(80.6%)310(19.4%)473(29.7%)1120(70.3%) 50-427(83.1%)87(16.9%)88.838\<0.001171(33.4%)341(66.6%)29.649\<0.001 60-127(79.4%)33(20.6%)59(36.9%)101(63.1%) 70-18(81.8%)4(18.2%)8(36.4%)14(63.6%)Gender Male1299(54.7%)356(50.4%)4.1300.042486(54.9%)1166(53.1%)0.7950.373 Female1076(45.3%)(35,149.6%)399(45.1%)1028(46.9%)

We firstly analyzed the seropositivity of anti-HAV IgG in the Chinese Han population. As the results shown, 2377 participants were determined with anti-HAV IgG positive (77.06%). Among of them, 1299 males (78.49%) were anti-HAV IgG positive, which was significantly higher than those in the females (75.40%, χ^2^ = 4.130, *P* = 0.042, Table [1](#Tab1){ref-type="table"}).

Next, anti-HEV IgG were measured in the studied population. Three samples were not measured because of samples insufficient. As the results shown, the seroprevalence of anti-HEV IgG was 28.72%. Four hundred eighty-six males (29.37%) and 399 females (27.96%) were positive for anti-HEV IgG, respectively. There was not significant deference between males and females (χ^2^ = 0.795, *P* = 0.373, Table [1](#Tab1){ref-type="table"}).

Genetic associations with anti-HAV IgG seropositivity {#Sec9}
-----------------------------------------------------

There were no significant deviations from HWE for the selected polymorphisms (Additional file [2](#MOESM2){ref-type="media"}: Table S2). As presented in Table [2](#Tab2){ref-type="table"}, rs1045642 C to T variation in ABCB1 and rs1001581 A to G variation in XRCC1 gene were significantly associated with the decreased risk of HAV infection (OR \< 1.0 adjusted for gender and age) in Chinese Han population. However, the remaining 3 SNPs, rs769214 in CAT, rs1800469 in TGFB1 and rs2031920 in CYP2E1, which were shown to be associated with HAV infection in Mexican Americans, were not associated with anti-HAV seropositivity in our samples (*P* \> 0.05, adjusted for gender and age; Table [2](#Tab2){ref-type="table"}). In subsequent gender-differentiated analyses, we did not observe any association of these five SNPs with HAV infection (Table [3](#Tab3){ref-type="table"}).Table 2Analysis on the association between SNPs selected from GWAS and anti-HAV IgG seropositivityGene nomenclatureSNPAnti-HAV IgGWT/HT/MTOR(95%CI)^a^AdditiveDominantRecessiveCATrs769214GG/GA/AAPositive1190/975/2010.979(0.858--1.117)0.966(0.815--1.144)1.000(0.738--1.355)Negative347/298/60*P* = 0.754*P* = 0.687*P* = 0.999XRCC1rs1001581AA/AG/GGPositive929/1040/4030.920(0.817--1.036)0.836(0.700--0.998)0.995(0.794--1.247)Negative247/338/120*P* = 0.168*P* = 0.047*P* = 0.966ABCB1rs1045642CC/CT/TTPositive913/1107/3460.862(0.763--0.974)0.835(0.699--0.997)0.802(0.638--1.007)Negative245/334/123*P* = 0.017*P* = 0.047*P* = 0.057TGFβ1rs1800469CC/CT/TTPositive600/1194/5720.918(0.813--1.037)0.878(0.719--1.073)0.908(0.747--1.104)Negative162/362/181*P* = 0.169*P* = 0.204*P* = 0.332CYP2E1rs2031920CC/CT/TTPositive1471/780/1130.868(0.754--1.001)0.851(0.716--1.012)0.799(0.551--1.159)Negative409/254/41*P* = 0.051*P* = 0.068*P* = 0.237*WT* wild type, *HT* heterozygote, *MT* mutant type^a^: Adjusted for age and sexTable 3Gender-stratification analysis on the association between selected SNPs and anti-HAV seropositivityGene nomenclatureSNPStratumAnti-HAV IgGWT/HT/MTOR(95%CI)/*P* value^a^AdditiveDominantRecessiveCATrs769214GG/GA/AAMalepositive654/525/1150.955(0.797--1.144)0.920(0.727--1.163)1.019(0.673--1.544)negative172/152/31*P* = 0.618*P* = 0.485*P* = 0.928Femalepositive536/450/860.994(0.822--1.201)1.000(0.786--1.273)0.965(0.622--1.498)negative175/146/29*P* = 0.946*P* = 1.000*P* = 0.875XRCC1rs1001581AA/AG/GGMalepositive491/577/2290.911(0.774--1.073)0.824(0.644--1.055)0.978(0.720--1.328)negative119/173/64*P* = 0.266*P* = 0.125*P* = 0.888Femalepositive438/463/1740.925(0.781--1.096)0.842(0.656--1.081)1.010(0.727--1.404)negative128/165/56*P* = 0.369*P* = 0.177*P* = 0.951ABCB1rs1045642CC/CT/TTMalepositive497/624/1740.848(0.714--1.007)0.827(0.646--1.059)0.773(0.561--1.067)negative120/174/59*P* = 0.061*P* = 0.131*P* = 0.117Femalepositive416/483/1720.900(0.759--1.067)0.879(0.684--1.129)0.852(0.621--1.169)negative125/160/64*P* = 0.224*P* = 0.312*P* = 0.321TGFβ1rs1800469CC/CT/TTMalepositive350/637/3070.910(0.771--1.074)0.820(0.623--1.079)0.947(0.721--1.244)negative83/185/88*P* = 0.265*P* = 0.156*P* = 0.697Femalepositive250/557/2650.947(0.796--1.127)0.962(0.721--1.283)0.904(0.687--1.190)negative79/177/93*P* = 0.542*P* = 0.792*P* = 0.471CYP2E1rs2031920CC/CT/TTMalepositive795/438/610.865(0.712--1.051)0.868(0.684--1.102)0.714(0.435--1.171)negative206/126/23*P* = 0.144*P* = 0.244*P* = 0.180Femalepositive676/342/520.860(0.702--1.052)0.810(0.633--1.037)0.938(0.542--1.628)negative203/128/18*P* = 0.142*P* = 0.094*P* = 0.823*WT* wild type, *HT* heterozygote, *MT* mutant type^a^ Adjusted for age

Genetic associations with anti-HEV IgG seropositivity {#Sec10}
-----------------------------------------------------

Table [4](#Tab4){ref-type="table"} summarized the associations between genetic variants in APOA4 and APOE genes and the risk of HEV infection. Rs7412-C in APOE, which was identified in American non-Hispanic blacks, was not associated with seropositivity of anti-HEV IgG in Chinese Han population (P \> 0.05, adjusted for gender and age). Similarly, the remaining three SNPs, rs1268534 in APOA4, rs405509 and rs769480 in APOE did not show any relationships with anti-HEV seropositivity.Table 4Analysis on the associations between SNPs selected from GWAS and anti-HEV IgG seropositivityGene nomenclatureSNPAnti-HEV IgGWT/HT/MTOR(95%CI)^a^AdditiveDominantRecessiveAPOA4rs1268354CC/CT/TTPositive341/413/1290.929(0.828--1.043)0.88(0.748--1.034)0.967(0.775--1.208)Negative778/1083/324*P* = 0.212*P* = 0.121*P* = 0.77APOErs405509TT/TG/GGPositive443/377/620.996(0.88--1.127)1.035(0.884--1.211)0.863(0.639--1.166)Negative1120/886/182*P* = 0.944*P* = 0.67*P* = 0.337rs7412CC/CT/TTPositive757/122/60.853(0.694--1.049)0.831(0.668--1.034)1.148(0.433--3.044)Negative1820/360/13P = 0.131*P* = 0.098*P* = 0.781rs769450AA/AG/GGPositive556/300/291.044(0.909--1.2)1.091(0.927--1.284)0.831(0.542--1.274)Negative1426/677/90P = 0.542*P* = 0.292*P* = 0.395*WT* wild type, *HT* heterozygote, *MT* mutant type^a^: Adjusted for age and sex

Interestingly, in subsequent gender-differentiated analyses, we observed that rs7412-C in APOE was significantly associated with the protection against HEV infection in Chinese Han males (OR \< 1.0 adjusted for age, Table [5](#Tab5){ref-type="table"}). However, no significant associations were detected in other three SNPs with HEV infection in the present population.Table 5Gender-stratification analysis on the association between selected SNPs and anti-HEV IgG seropositivityGene nomenclatureSNPStratumAnti-HEV IgGWT/HT/MTOR(95%CI)/*P* value^a^AdditiveDominantRecessiveAPOA4rs1268354CC/CT/TTMalepositive187/223/750.963(0.823--1.126)0.893(0.754--1.059)0.883(0.708--1.101)negative412/587/163*P* = 0.634*P* = 0.194*P* = 0.268Femalepositive154/190/540.88(0.692--1.117)1.095(0.812--1.476)0.833(0.597--1.162)negative366/496/161*P* = 0.293*P* = 0.553*P* = 0.282APOErs405509TT/TG/GGMalepositive243/209/320.941(0.796--1.112)1.076(0.894--1.294)0.998(0.806--1.235)negative581/472/111*P* = 0.473*P* = 0.440*P* = 0.984Femalepositive200/168/301.089(0.864--1.374)0.713(0.472--1.075)1.114(0.714--1.737)negative539/414/71*P* = 0.471*P* = 0.106*P* = 0.635rs7412CC/CT/TTMalepositive422/63/10.707(0.527--0.95)1.036(0.775--1.385)0.708(0.522--0.96)negative958/210/6*P* = 0.021*P* = 0.811*P* = 0.026Femalepositive335/59/50.998(0.728--1.367)0.351(0.042--2.958)1.895(0.597--6.014)negative862/159/7*P* = 0.988*P* = 0.336*P* = 0.278rs769450AA/AG/GGMalepositive297/176/131.086(0.9--1.311)1.004(0.817--1.235)1.195(0.959--1.49)negative758/355/52*P* = 0.389*P* = 0.967*P* = 0.112Femalepositive259/124/160.988(0.775--1.26)0.632(0.34--1.177)1.116(0.614--2.027)negative668/322/38*P* = 0.924*P* = 0.148*P* = 0.719*WT* wild type, *HT* heterozygote, *MT* mutant type^a^ Adjusted for age

Discussions {#Sec11}
===========

In this study, we attempted to evaluate the GWAS-associated SNPs from ABCB1, CYP2E1, CAT, TGFB1 and XRCC1 with HAV infection, and SNPs from APOA4 and APOE with HEV infection in Chinese Han populations, respectively. However, the conflicting results were observed in the present study. First, our results found that rs1045642 C to T variation was associated with the decreased risk of HAV infection in Chinese Han persons, while the results from US study indicated that individuals with T allele of rs1045642 were less prone to be infected by HAV \[[@CR8]\]. Second, we observed that rs1001581A to G variation in XRCC1 was significantly associated with protection against HAV infections, whereas this association was not observed in US population. Lastly, Zhang et al. reported that variants in APOA4 and APOE were significantly associated with the lower odds of anti-HEV seropositivity \[[@CR13]\]. However, our results only suggested that rs7412 C to T variation in APOE was associated with decreased risks of HEV infection in Chinese Han males.

Several factors could contribute to the differences between our present study and the previous US study. One factor could be ascribed to the genetic heterogeneity of virus. HAV and HEV could be divided into six genotypes (I-VI) and four major genotypes (1--4), respectively \[[@CR18], [@CR19]\]. Both HAV and HEV genotypes exhibited a particular geographic distribution \[[@CR20]--[@CR22]\]. Although subgenotype IA HAV constitutes a major fraction of genotype I strains circulating in US and China, the virus strains from the US and China could be further divided into different clusters \[[@CR23], [@CR24]\]. In addition, genotype 3 HEV is the main genotype circulating in US, while genotype 4 HEV strain is the dominant genotype in China \[[@CR25]--[@CR27]\]. Thus, the effects of the genetic variation of viruses on the risk of infection in different ethnicities should be investigated in future. Additionally, although the allele frequencies of tested polymorphisms were similar between two studies, the genetic differences among ethnicities might be as the other explanation for the present results (Additional file [3](#MOESM3){ref-type="media"}: Table S3) \[[@CR28], [@CR29]\]. Therefore, replication studies in different racial/ethnic groups are encouraged.

To our knowledge, this is the first replication study to explore the associations between GWAS-associated SNPs and HAV or HEV infection in China. However, there are several general limitations should be considered. First, although the number of study participants met the requirement for analysis, independent replications in larger population should be conducted in future. Second, our study only sought to replicate the limited SNPs in a Chinese Han population because we felt such a replication would be a critical first step to understanding these results. Greater genome coverage and more informative markers including APOE isoforms are required in order to realize true genetic determinants of hepatitis A and E infections. Last, it is well known that HAV or HEV infections are significantly associated with environmental and social factors. Thus, gene-gene and gene-environment interaction on the risks of virus infection should be further discussed.

Conclusions {#Sec12}
===========

Summary, our present study suggested that ABCB1 and XRCC1 genes variants were significantly associated with the lower risk of HAV infection. Additionally, Chinese Han males with rs7412 C to T variation in APOE are less prone to be infected by HEV. In order to further understand the effects of host genetic factors on HAV or HEV infection in different ethnic populations, more studies using a large-scale association analysis should be warranted in future.
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